Armando Magagna

Author PubWeight™ 17.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation 2009 1.49
2 Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003 1.48
3 Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003 1.43
4 Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension 2008 1.39
5 Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007 1.36
6 Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 2006 1.05
7 Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 2007 0.96
8 Local carotid stiffness and intima-media thickness assessment by a novel ultrasound-based system in essential hypertension. Atherosclerosis 2012 0.87
9 Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens 2011 0.87
10 Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest. Hypertension 2005 0.85
11 Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). Trials 2013 0.82
12 Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 2008 0.81
13 Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens 2003 0.80
14 Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009 0.79
15 Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication. Blood Press 2008 0.79
16 An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy. High Blood Press Cardiovasc Prev 2012 0.79
17 Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension 2007 0.78
18 Myocardial perfusion response to dipyridamole in hypertensive left ventricular hypertrophy: a human study using myocardial contrast echocardiography. Microvasc Res 2002 0.75